Effects of yoga-based and conventional physiotherapy programs on functional, respiratory, and psychosocial outcomes in stage II sarcoidosis: a randomized controlled trial

This is a preview and has not been published.

Effects of yoga-based and conventional physiotherapy programs on functional, respiratory, and psychosocial outcomes in stage II sarcoidosis: a randomized controlled trial

Authors

  • Şeyda Yıldız Department of Physiotherapy and Rehabilitation, University of Health Sciences, Istanbul, Türkiye https://orcid.org/0000-0002-3917-2286
  • Murat KAVAS University of Health Sciences, Istanbul Sureyyapasa Chest Diseases and Thoracic Surgery Training and Research Hospital, Department of Pulmonology, Istanbul, Türkiye https://orcid.org/0000-0001-9025-6605
  • Zuhal Didem TAKİNACI Department of Physiotherapy and Rehabilitation, Faculty of Health Sciences, University of Health Sciences, Istanbul, Türkiye https://orcid.org/0000-0001-5569-5282
  • Selma AYDOĞAN EROĞLU University of Health Sciences, Istanbul Sureyyapasa Chest Diseases and Thoracic Surgery Training and Research Hospital, Department of Pulmonology, Istanbul, Türkiye https://orcid.org/0000-0003-4210-6957

Keywords:

Sarcoidosis, Yoga, Physiotherapy, Telerehabilitation, Exercise

Abstract

Background and aim: Sarcoidosis, a multisystemic granulomatous disease, presents with various clinical symptoms such as deterioration in respiratory functions, decreased exercise capacity, fatigue, sleep disorders, anxiety-depression, and consequently reduced quality of life. A standard rehabilitation protocol has not been defined for sarcoidosis, and due to the nature of the disease, holistic approaches are crucial in this group, which is known to have multisystem involvement. Therefore, this study aims to contribute to the development of future rehabilitation protocols by comparing the effectiveness of yoga and conventional physiotherapy programs delivered via telerehabilitation, in addition to standard aerobic training, in sarcoidosis patients with pulmonary involvement.

Methods: Thirty-four Stage II sarcoidosis patients were included in this study, and the participants were randomly divided into two groups (conventional physiotherapy, n=16, yoga, n=18). Before and after the 8-week programs, participants completed the following questionnaires: Fatigue Assessment Scale (FAS), Hospital Anxiety and Depression Scale, Pittsburgh Sleep Quality Index (PSQI), and St. George Respiratory Questionnaire (SGRQ). Furthermore, the 6MWT, Body Oxygen Level Test (BOLT), spirometric measurements, DLCO, Maximum inspiratory pressure (MIP), and dyspnea (mMRC score) measurements.

Results: Programs significantly improved exercise capacity, inspiratory muscle strength, fatigue (FAS), dyspnea, PSQI scores, anxiety-depression levels, quality of life (SGRQ), and BOLT time in both groups. While similar improvements were observed overall in intergroup comparisons, the increase in MIP and BOLT time was more pronounced in the conventional physiotherapy group. Neither program resulted in significant changes in spirometric parameters or DLCO values.

Conclusions: This study found that both 8-week telerehabilitation-based yoga and conventional physiotherapy programs were effective for patients with Stage II sarcoidosis. The similar effects observed between yoga and conventional physiotherapy suggest that yoga, a holistic mind-body approach, may be an effective alternative in the treatment of sarcoidosis.

Author Biographies

Şeyda Yıldız, Department of Physiotherapy and Rehabilitation, University of Health Sciences, Istanbul, Türkiye

Şeyda Yıldız is a Lecturer in the Department of Physiotherapy and Rehabilitation at Istanbul Health and Technology University, Istanbul, Türkiye, and a PhD candidate in Physiotherapy and Rehabilitation at the University of Health Sciences, Istanbul, Türkiye.

Murat KAVAS, University of Health Sciences, Istanbul Sureyyapasa Chest Diseases and Thoracic Surgery Training and Research Hospital, Department of Pulmonology, Istanbul, Türkiye

Assoc. Prof. Dr. Murat Kavas is a Chest Diseases Specialist (Pulmonologist) and Associate Professor in the Department of Pulmonology at the University of Health Sciences, Istanbul Sureyyapasa Chest Diseases and Thoracic Surgery Training and Research Hospital, Istanbul, Türkiye.

Zuhal Didem TAKİNACI, Department of Physiotherapy and Rehabilitation, Faculty of Health Sciences, University of Health Sciences, Istanbul, Türkiye

Dr. Zuhal Didem TAKİNACI is an Assistant Professor in the Department of Physiotherapy and Rehabilitation at the University of Health Sciences, Istanbul, Türkiye.

Selma AYDOĞAN EROĞLU, University of Health Sciences, Istanbul Sureyyapasa Chest Diseases and Thoracic Surgery Training and Research Hospital, Department of Pulmonology, Istanbul, Türkiye

Assoc. Prof. Dr. Selma AYDOĞAN EROĞLU is a Chest Diseases Specialist (Pulmonologist) and Associate Professor in the Department of Pulmonology at the University of Health Sciences, Istanbul Sureyyapasa Chest Diseases and Thoracic Surgery Training and Research Hospital, Istanbul, Türkiye.

References

References

1. Kavas M, Kaymaz S, Aydoğan Eroglu S, Karasu U, Cobankara V, Boga S. Validation of the Turkish version of the Sarcoidosis Health Questionnaire: a cross-sectional study. Sarcoidosis Vasc Diffuse Lung Dis 2023; 40 (1): e2023002.

2. Waly YM, Sharafeldin A-BK, Akhtar MU, Chilmeran Z, Fredericks S. A review of sarcoidosis etiology, diagnosis, and treatment. Front Med 2025;12:1558049.

3. Hunninghake GW, Costabel U, Ando M, et al. ATS/ERS/WASOG statement on sarcoidosis. American Thoracic Society/European Respiratory Society/World Association of Sarcoidosis and other Granulomatous Disorders. Sarcoidosis Vasc Diffuse Lung Dis 1999;16 (2): 149-73.

4. Drent M, Marcellis R, Lenssen A, De Vries J. Association between physical functions and quality of life in sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2014; 31(2):117-28.

5. Spruit MA, Thomeer MJ, Gosselink R, et al. Skeletal muscle weakness in patients with sarcoidosis and its relationship with exercise intolerance and reduced health status. Thorax 2005; 60(1): 32-8.

6. Baughman RP, Valeyre D, Korsten P, Mathioudakis AG, Wuyts WA, Wells A, et al. ERS clinical practice guidelines on treatment of sarcoidosis. Eur Respir J 2021; 58(6):2004079. Available from: https://publications.ersnet.org//content/erj/58/6/2004079.abstract

7. Alsina-Restoy X, Torres-Castro R, Caballería E, et al. Pulmonary rehabilitation in sarcoidosis: A systematic review and meta-analysis. Respir Med 2023; 219:107432.

8. Naz I, Ozalevli S, Ozkan S, Sahin H. Efficacy of a structured exercise program for improving functional capacity and quality of life in patients with stage 3 and 4 sarcoidosis: a randomized controlled trial. J Cardiopulm Rehabil Prev 2018; 38(2):124-30.

9. Khattab K, Khattab AA, Ortak J, Richardt G, Bonnemeier H. Iyengar yoga increases cardiac parasympathetic nervous modulation among healthy yoga practitioners. Evid Based Complement Alternat Med 2007;4 (4): 511–7.

10. Liu X-C, Pan L, Hu Q, Dong W-P, Yan J-H, Dong L. Effects of yoga training in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis. J Thorac Dis 2014; 6(6): 795–802.

11. Dua R, Malik S, Bhadoria AS, Neyaz O, Krishnan AS, Pandya C. Effectiveness of telemedicine interventions in chronic obstructive pulmonary disease (COPD) Management: a randomized controlled trial comparing yoga therapy and pulmonary rehabilitation over Three Months. Cureus 2024;16 (3): e56060.

12. Jayawardena R, Ranasinghe P, Ranawaka H, Gamage N, Dissanayake D, Misra A. Exploring the therapeutic benefits of pranayama (yogic breathing): a systematic review. Int J Yoga 2020;13 (2): 99–110.

13. Zaccaro A, Piarulli A, Laurino M, et al. How breath-control can change your life: a systematic review on psycho-physiological correlates of slow breathing. Front Hum Neurosci 2018; 12: 353.

14. Kumari S, Nadholta P, Dahiya N, et al. Link between yoga and heart rate variability: can yoga enhance the cardiac resonance. Int J Yoga 2024; 17(2): 67–75.

15. Jones PW. St. George’s Respiratory Questionnaire: MCID. COPD 2005; 2 (1): 75–9.

16. Belperio JA, Fishbein MC, Abtin F, Channick J, Balasubramanian SA, Lynch Iii JP. Pulmonary sarcoidosis: A comprehensive review: past to present. J Autoimmun 2024;149:103107.

17. Faul F, Erdfelder E, Buchner A, Lang A-G. Statistical power analyses using G* Power 3.1: Tests for correlation and regression analyses. Behav Res Methods 2009; 41 (4): 1149-60.

18. Cohen J. Statistical power analysis for the behavioural sciences. 2nd

ed. Hillsdale (NJ): Lawrence Erlbaum Associates; 1988.

19. Michielsen HJ, De Vries J, Van Heck GL. Psychometric qualities of a brief self-rated fatigue measure: The Fatigue Assessment Scale. J Psychosom Res 2003; 54 (4): 345-52.

20. Selcuk D. Doğum sonu dönemdeki kadınlarda yorgunluk değerlendirme ölçeği'nin Türkçe psikometrik özellikleri [master’s thesis]. Izmir (Türkiye): Ege University, Institute of Health Sciences; 2019.

21. Miller MR, Hankinson J, Brusasco V, et al. Standardisation of spirometry. Eur Respir J 2005; 26 (2): 319-38.

22. Miller MR, Crapo R, Hankinson J, et al. General considerations for lung function testing. Eur Respir J 2005 Jul; 26 (1): 153-61.

23. Rochester CL, Vogiatzis I, Holland AE, et al. An Official American Thoracic Society/European Respiratory Society Policy Statement: Enhancing implementation, use, and delivery of pulmonary rehabilitation. Am J Respir Crit Care Med 2015; 192 (11): 1373-86.

24. Baughman RP, Sparkman BK, Lower EE. Six-minute walk test and health status assessment in sarcoidosis. Chest 2007;132 (1): 207-13.

25. Kabitz H-J, Lang F, Walterspacher S, Sorichter S, Müller-Quernheim J, Windisch W. Impact of impaired inspiratory muscle strength on dyspnea and walking capacity in sarcoidosis. Chest 2006; 130(5):1496-502.

26. Baydur A, Alsalek M, Louie SG, Sharma OP. Respiratory muscle strength, lung function, and dyspnea in patients with sarcoidosis. Chest 2001; 120 (1): 102-8.

27. Stenton C. The MRC breathlessness scale. Occup Med (Lond) 2008; 58 (3): 226-7.

28. Polatlı M, Yorgancıoğlu A, Aydemir Ö, et al. Validity and reliability of Turkish version of St. George’s respiratory questionnaire. Tuberk Toraks 2013; 61 (2): 81-7.

29. Aydemir Ö, Guvenir T, Kuey L, Kultur S. Validity and reliability of Turkish version of hospital anxiety and depression scale. Turk Psikiyatr Derg 1997; 8 (4): 280-7.

30. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983; 67 (6): 361-70.

31. Buysse DJ, Reynolds CF 3rd, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res 1989; 28 (2): 193-213.

32. Ağargün MY, Kara H, Anlar O. Pittsburgh uyku kalitesi indeksinin geçerliği ve güvenirliği. Türk Psikiyatr Derg 1996; 7 (2): 107-15.

33. Kowalski T, Rebis K, Wilk A, Klusiewicz A, Wiecha S, Paleczny B. Body Oxygen Level Test (BOLT) is not associated with exercise performance in highly-trained individuals. Front Physiol 2024;15:1430837.

34. Barnai M, Laki I, Gyurkovits K, Angyan L, Horvath G. Relationship between breath-hold time and physical performance in patients with cystic fibrosis. Eur J Appl Physiol 2005; 95 (2-3): 172-8.

35. Yeo J, Kim JY, Kim MH, Park JW, Park JK, Lee EB. Utility of the breath-holding test in patients with systemic sclerosis. Rheumatology (Oxford) 2022; 61 (10): 4113-8.

36. Hedhli A, Slim A, Ouahchi Y, et al. Maximal voluntary breath-holding tele-inspiratory test in patients with Chronic Obstructive Pulmonary Disease. Am J Mens Health 2021;

15 (3): 15579883211015856.

37. ATS/ERS Statement on respiratory muscle testing. Am J Respir Crit Care Med 2002; 166 (4): 518-624.

38. Black LF, Hyatt RE. Maximal respiratory pressures: normal values and relationship to age and sex. Am Rev Respir Dis 1969; 99 (5): 696-702.

39. Evans JA, Whitelaw WA. The assessment of maximal respiratory mouth pressures in adults. Respir Care 2009; 54 (10): 1348-59.

40. Kahlmann V, Moor CC, van Helmondt SJ, et al. Online mindfulness-based cognitive therapy for fatigue in patients with sarcoidosis (TIRED): a randomised controlled trial. Lancet Respir Med 2023; 11 (3): 265-72.

41. Saketkoo LA, Karpinski A, Young J, et al. Feasibility, utility and symptom impact of modified mindfulness training in sarcoidosis. ERJ open Res 2018; 4 (2): 00085-2017.

42. Valeyre D, Prasse A, Nunes H, Uzunhan Y, Brillet PY, Müller-Quernheim J. Sarcoidosis. Lancet 2014; 383 (9923):1155-67.

43. Yoon H-Y, Kim HM, Kim Y-J, Song JW. Prevalence and incidence of sarcoidosis in Korea: a nationwide population-based study. Respir Res 2018; 19 (1): 158.

44. Tunç Ş, Yıldız P, Sungur MA. Impact of nutritional status in sarcoidosis patients. Sarcoidosis Vasc Diffuse Lung Dis 2025; 42 (3): 16968.

45. Tana C, Drent M, Nunes H, et al. Comorbidities of sarcoidosis. Ann Med 2022; 54 (1): 1014-35.

46. Cerdan de Las Heras J, Balbino F, Catalán-Matamoros D, Løkke A, Hilberg O, Bendstrup E. Effect of a Telerehabilitation program in sarcoidosis. Sarcoidosis Vasc Diffuse lung Dis 2022; 39 (1): e2022003.

47. Yang ZY, Zhong HB, Mao C, et al. Yoga for asthma. Cochrane Database Syst Rev 2016; 4(4): CD010346.

48. Hei L, Zhang Y, Si Y, Bai L. Yoga for psychological outcomes and quality of life in non-cystic fibrosis bronchiectasis: a controlled study. Front Psychiatry 2025; 16: 1695692.

49. Santana MJ, S-Parrilla J, Mirus J, Loadman M, Lien DC, Feeny D. An assessment of the effects of Iyengar yoga practice on the health-related quality of life of patients with chronic respiratory diseases: a pilot study. Can Respir J 2013; 20(2): e17-e23.

50. Tan MS, Algun ZC, Duger M, Aslan Keles Y. The effect of yoga on dyspnea, sleep, and quality of life in patients with bronchiectasis: A randomized controlled trial. Complement Ther Clin Pract 2024; 57: 101914.

51. Atkins C, Wilson AM. Managing fatigue in sarcoidosis - A systematic review of the evidence. Chron Respir Dis 2017; 14 (2): 161-73.

52. de Kleijn WPE, De Vries J, Wijnen PAHM, Drent M. Minimal (clinically) important differences for the Fatigue Assessment Scale in sarcoidosis. Respir Med 2011; 105 (9): 1388-95.

53. Grongstad A, Spruit MA, Oldervoll LM, Vøllestad NK, Edvardsen A. Pulmonary rehabilitation in patients with pulmonary sarcoidosis: Impact on exercise capacity and fatigue. Respiration 2020; 99 (4): 289-97.

54. Tahmaz T, Aslan GK, Yeldan İ, Okumuş NG. Comparison of the effects of one-legged and two-legged exercise training on exercise capacity and fatigue in patients with sarcoidosis. Respir Med 2025; 248: 108380.

55. Strookappe B, Swigris J, De Vries J, Elfferich M, Knevel T, Drent M. Benefits of physical training in sarcoidosis. Lung 2015; 193 (5): 701-8.

56. Nici L, Lareau S, ZuWallack R. Pulmonary rehabilitation in the treatment of chronic obstructive pulmonary disease. Am Fam Physician 2010; 82 (6): 655-60.

57. Nishino T. Pathophysiology of dyspnea evaluated by breath-holding test: studies of furosemide treatment. Respir Physiol Neurobiol 2009; 167 (1): 20-5.

58. Hassan Nabih Mohamed M, Abdel Hamid Mohamed A, Elsayed Mosaad Mohammed S. Effectiveness of pulmonary rehabilitation with exercise training in improving health outcomes for patients with chronic obstructive pulmonary disease. Egypt J Heal Care 2024; 15 (3): 425-36.

59. Vagedes K, Kuderer S, Ehmann R, et al. Effect of Buteyko breathing technique on clinical and functional parameters in adult patients with asthma: a randomized, controlled study. Eur J Med Res 2024; 29 (1): 42.

60. Lingner H, Buhr-Schinner H, Hummel S, et al. Short-term effects of a multimodal 3-week inpatient pulmonary rehabilitation programme for patients with sarcoidosis: the ProKaSaRe study. Respiration 2018; 95 (5): 343-53.

61. Guber E, Wand O, Epstein Shochet G, Romem A, Shitrit D. The short- and long-term impact of pulmonary rehabilitation in subjects with sarcoidosis: a prospective study and review of the literature. Respiration 2021; 100 (5): 423-31.

62. Jagadeesan T, Archana R, Kannan R, et al. Effect of Bhramari Pranayama intervention on stress, anxiety, depression and sleep quality among COVID 19 patients in home isolation. J Ayurveda Integr Med 2022; 13 (3): 100596.

63. Ray LN, O’Connor PJ. Session of yoga, with and without slow (Ujjayi) breathing, reduces anxiety; no change on acute pain sensitivity and endogenous pain modulation. Explore (NY) 2023; 19 (3): 362-70.

64. Brown TA, Chorpita BF, Barlow DH. Structural relationships among dimensions of the DSM-IV anxiety and mood disorders and dimensions of negative affect, positive affect, and autonomic arousal. J Abnorm Psychol 1998; 107 (2): 179-92.

65. Tolentino JC, Schmidt SL. DSM-5 criteria and depression severity: implications for clinical practice. Front psychiatry 2018; 9: 450.

66. Bosse-Henck A, Wirtz H, Hinz A. Subjective sleep quality in sarcoidosis. Sleep Med 2015; 16 (5): 570-6.

67. Hinz A, Glaesmer H, Brähler E, et al. Sleep quality in the general population: psychometric properties of the Pittsburgh Sleep Quality Index, derived from a German community sample of 9284 people. Sleep Med 2017; 30: 57-63.

68. Baglioni C, Battagliese G, Feige B, et al. Insomnia as a predictor of depression: a meta-analytic evaluation of longitudinal epidemiological studies. J Affect Disord 2011; 135 (1): 10-9.

69. Alvaro PK, Roberts RM, Harris JK. A systematic review assessing bidirectionality between sleep disturbances, anxiety, and depression. Sleep 2013; 36 (7): 1059-68.

70. Beaumont M, Couasnon C, Péran L, Berriet AC, Ber C Le, Pichon R. Determination of the minimal important difference for inspiratory muscle strength in people with severe and very severe COPD. Clin Rehabil 2023; 37 (11): 1521-32.

71. Iwakura M, Okura K, Kubota M, et al. Estimation of minimal clinically important difference for quadriceps and inspiratory muscle strength in older outpatients with chronic obstructive pulmonary disease: a prospective cohort study. Phys Ther Res 2021; 24 (1): 35-42.

72. Rømer FK. Presentation of sarcoidosis and outcome of pulmonary changes. Dan Med Bull 1982; 29 (1): 27-32.

73. Dubrey S, Sharma R, Underwood R, Mittal T, Wells A. Sarcoidosis of the cardio-pulmonary systems. Clin Med 2016; 16 (1): 34-41.

74. Hun Kim S, Beom Shin Y, Shin M-J, et al. Effects of walking with a portable oxygen concentrator on muscle oxygenation while performing normal or pursed-lip breathing in patients with interstitial lung disease: a randomized crossover trial. Ther Adv Respir Dis 2023; 17: 17534666231186732.

75. Hamasaki H. Effects of diaphragmatic breathing on health: a narrative review. Medicines (Basel) 2020; 7(10): 65.

76. Ahmad AM. Essentials of physiotherapy after thoracic surgery: what physiotherapists need to know. A narrative review. Korean J Thorac Cardiovasc Surg 2018; 51 (5): 293-307.

77. Erdogan Yuce G, Tasci S. Retraining of breathing in asthma management: pranayama breathing technique. Turkiye Klinikleri J Nurs Sci 2019; 11 (4): 409-16.

78. Önder ÖÖ. Efficacy of yoga and pranayama on sleep disorders. Sleep Vigil 2019; 3 (2): 95-100.

79. Saoji AA, Raghavendra BR, Manjunath NK. Effects of yogic breath regulation: a narrative

review of scientific evidence. J Ayurveda Integr Med 2019; 10(1): 50-8.

80. Morse D. Yoga for asthma. International Journal of Yoga Therapy 2007; 17 (1): 81-8.

81. Saraswati S. Asana, pranayama, mudra bandha. 4th ed. Munger (Bihar, India): Yoga

Publications Trust; 2012.

82. Kuppusamy M, Kamaldeen D, Pitani R, Amaldas J, Shanmugam P. Effects of

Bhramari Pranayama on health–a systematic review. J Tradit Complement Med 2018; 8 (1); 11-6.

83. Lin IM, Tai LY, Fan SY. Breathing at a rate of 5.5 breaths per minute with equal inhalation- to-exhalation ratio increases heart rate variability. Int J Psychophysiol 2014; 91 (3): 206-11.

84. Russo MA, Santarelli DM, O’Rourke D. The physiological effects of slow breathing in

the healthy human. Breathe (Sheff) 2017; 13 (4): 298-309.

85. Önder ÖÖ. Nefesten Solunuma. 1st ed. Istanbul (Türkiye): Kuraldışı Yayıncılık; 2019.

86. Ansari RM. Kapalabhati pranayama: an answer to modern day polycystic ovarian

syndrome and coexisting metabolic syndrome? Int J Yoga 2016; 9 (2): 163-7.

87. Vedala SR, Mane AB, Paul CN. Pulmonary functions in yogic and sedentary

population. Int J Yoga 2014; 7(2): 155-9.

88. Cottingham JT, Porges SW, Richmond K. Shifts in pelvic inclination angle and

parasympathetic tone produced by Rolfing soft tissue manipulation. Phys Ther 1988;

68(9):1364-70.

89. Andersen TE, Lahav Y, Ellegaard H, Manniche C. A randomized controlled trial of brief

Somatic Experiencing for chronic low back pain and comorbid post-traumatic stress disorder

symptoms. Eur J Psychotraumatol 2017; 8 (1): 1331108.

90. Siccardi MA, Tariq MA, Valle C. Anatomy, bony pelvis and lower limb: psoas major. In:

StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025. Available from:

https://www.ncbi.nlm.nih.gov/books/NBK535418/

91. Reinhart M, Jonsson M, Enthoven P, Westerdahl E. Immediate effects of upper limb

exercises with and without deep breathing on lung function after cardiac surgery: a

randomized crossover trial. J Cardiothorac Surg 2024; 19 (1): 503.

92. Couser JI Jr, Martinez FJ, Celli BR. Respiratory response and ventilatory muscle

recruitment during arm elevation in normal subjects. Chest 1992; 101 (2), 336-40.

93. Couser JI Jr, Martinez FJ, Celli BR. Pulmonary rehabilitation that includes arm exercise

reduces metabolic and ventilatory requirements for simple arm elevation. Chest 1993; 103

(1): 37-41.

94. El Melhat AM, El Khatib A, Youssef ASA, et al. Influence of changing hip position on

electromyographic activities of selected trunk muscles during bridging exercises in

healthy subjects: a cross-sectional study. J Manipulative Physiol Ther 2024; 47 (1): 12-21.

95. Neto WK, Soares EG, Vieira TL, et al. Gluteus maximus activation during common strength

and hypertrophy exercises: a systematic review. J Sports Sci Med 2020; 19 (1): 195-203.

96. Dewan M, Nijhawan M, Chhabra HS, Shandilya S, Kumar P, Phadke V. Electromyographic

analysis of trunk and hip muscles during yoga poses prescribed for treating chronic low back

pain. J Bodyw Mov Ther 2023; 36: 117-24.

How to Cite

1.
Yıldız Şeyda, KAVAS M, TAKİNACI ZD, AYDOĞAN EROĞLU S. Effects of yoga-based and conventional physiotherapy programs on functional, respiratory, and psychosocial outcomes in stage II sarcoidosis: a randomized controlled trial. Sarcoidosis Vasc Diffuse Lung Dis [Internet]. [cited 2026 May 15];43(3):18324. Available from: https://mattioli1885journals.com/index.php/sarcoidosis/article/view/18324

Issue

Section

Original Articles: Clinical Research

How to Cite

1.
Yıldız Şeyda, KAVAS M, TAKİNACI ZD, AYDOĞAN EROĞLU S. Effects of yoga-based and conventional physiotherapy programs on functional, respiratory, and psychosocial outcomes in stage II sarcoidosis: a randomized controlled trial. Sarcoidosis Vasc Diffuse Lung Dis [Internet]. [cited 2026 May 15];43(3):18324. Available from: https://mattioli1885journals.com/index.php/sarcoidosis/article/view/18324